Patient group input submissions: Sapropterin dihydrochloride (Kuvan) for phenylketonuria (PKU)

Questionnaires were promoted to patients with phenylketonuria to gather input on the effectiveness of sapropterin dihydrochloride in the treatment of the disease

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2017, 2017 Sep
Series:CADTH common drug review
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:Questionnaires were promoted to patients with phenylketonuria to gather input on the effectiveness of sapropterin dihydrochloride in the treatment of the disease
Physical Description:1 PDF file (12 pages) illustrations